NHNKY
Price
$13.18
Change
+$0.05 (+0.38%)
Updated
Jun 5 closing price
Capitalization
2.23B
NNCSF
Price
$2.61
Change
-$0.19 (-6.79%)
Updated
Jun 4 closing price
Capitalization
962.45M
Interact to see
Advertisement

NHNKY vs NNCSF

Header iconNHNKY vs NNCSF Comparison
Open Charts NHNKY vs NNCSFBanner chart's image
Nihon Kohden
Price$13.18
Change+$0.05 (+0.38%)
Volume$1.28K
Capitalization2.23B
Nanosonics
Price$2.61
Change-$0.19 (-6.79%)
Volume$1.39K
Capitalization962.45M
NHNKY vs NNCSF Comparison Chart
Loading...
NHNKY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NHNKY vs. NNCSF commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NHNKY is a StrongBuy and NNCSF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (NHNKY: $13.18 vs. NNCSF: $2.61)
Brand notoriety: NHNKY and NNCSF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NHNKY: 15% vs. NNCSF: 35%
Market capitalization -- NHNKY: $2.23B vs. NNCSF: $962.45M
NHNKY [@Medical Specialties] is valued at $2.23B. NNCSF’s [@Medical Specialties] market capitalization is $962.45M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NHNKY’s FA Score shows that 2 FA rating(s) are green whileNNCSF’s FA Score has 1 green FA rating(s).

  • NHNKY’s FA Score: 2 green, 3 red.
  • NNCSF’s FA Score: 1 green, 4 red.
According to our system of comparison, NHNKY is a better buy in the long-term than NNCSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NHNKY’s TA Score shows that 6 TA indicator(s) are bullish.

  • NHNKY’s TA Score: 6 bullish, 2 bearish.

Price Growth

NHNKY (@Medical Specialties) experienced а +9.70% price change this week, while NNCSF (@Medical Specialties) price change was -13.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.32%. For the same industry, the average monthly price growth was +4.56%, and the average quarterly price growth was +1.00%.

Reported Earning Dates

NHNKY is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Medical Specialties (+0.32% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NHNKY($2.23B) has a higher market cap than NNCSF($962M). NNCSF has higher P/E ratio than NHNKY: NNCSF (138.89) vs NHNKY (18.12). NNCSF YTD gains are higher at: 24.286 vs. NHNKY (-8.153). NHNKY has higher annual earnings (EBITDA): 27.2B vs. NNCSF (17.1M). NHNKY has more cash in the bank: 43.7B vs. NNCSF (94.5M). NNCSF has less debt than NHNKY: NNCSF (11.7M) vs NHNKY (433M). NHNKY has higher revenues than NNCSF: NHNKY (202B) vs NNCSF (142M).
NHNKYNNCSFNHNKY / NNCSF
Capitalization2.23B962M232%
EBITDA27.2B17.1M159,064%
Gain YTD-8.15324.286-34%
P/E Ratio18.12138.8913%
Revenue202B142M142,254%
Total Cash43.7B94.5M46,243%
Total Debt433M11.7M3,701%
FUNDAMENTALS RATINGS
NHNKY vs NNCSF: Fundamental Ratings
NHNKY
NNCSF
OUTLOOK RATING
1..100
7081
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
94
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
1058
PRICE GROWTH RATING
1..100
6254
P/E GROWTH RATING
1..100
6118
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NHNKY's Valuation (16) in the null industry is significantly better than the same rating for NNCSF (94). This means that NHNKY’s stock grew significantly faster than NNCSF’s over the last 12 months.

NHNKY's Profit vs Risk Rating (100) in the null industry is in the same range as NNCSF (100). This means that NHNKY’s stock grew similarly to NNCSF’s over the last 12 months.

NHNKY's SMR Rating (10) in the null industry is somewhat better than the same rating for NNCSF (58). This means that NHNKY’s stock grew somewhat faster than NNCSF’s over the last 12 months.

NNCSF's Price Growth Rating (54) in the null industry is in the same range as NHNKY (62). This means that NNCSF’s stock grew similarly to NHNKY’s over the last 12 months.

NNCSF's P/E Growth Rating (18) in the null industry is somewhat better than the same rating for NHNKY (61). This means that NNCSF’s stock grew somewhat faster than NHNKY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NHNKY
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
76%
Momentum
ODDS (%)
Bullish Trend 1 day ago
68%
MACD
ODDS (%)
Bullish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
64%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
63%
Advances
ODDS (%)
Bullish Trend 1 day ago
58%
Declines
ODDS (%)
Bearish Trend 11 days ago
64%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
75%
Aroon
ODDS (%)
Bullish Trend 1 day ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
NHNKY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GEMMX25.46N/A
N/A
GMO Emerging Markets VI
GCLLX16.23N/A
N/A
Goldman Sachs Enhanced U.S. Equity C
MFWIX17.15N/A
N/A
MFS Global Total Return I
GPROX15.97N/A
N/A
Grandeur Peak Global Reach Inv
GQERX21.68N/A
N/A
GQG Partners US Select Quality Eq R6

NNCSF and

Correlation & Price change

A.I.dvisor tells us that NNCSF and ASAPF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NNCSF and ASAPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NNCSF
1D Price
Change %
NNCSF100%
N/A
ASAPF - NNCSF
21%
Poorly correlated
+2.32%
NHNKY - NNCSF
8%
Poorly correlated
+0.41%
NHNKF - NNCSF
0%
Poorly correlated
N/A
NVYTF - NNCSF
0%
Poorly correlated
N/A
MRCHF - NNCSF
0%
Poorly correlated
+1.71%
More